Published in Br Med J (Clin Res Ed) on April 30, 1983
Cystic fibrosis--a gastroenterological cornucopia. Gut (1987) 1.11
Distal intestinal obstruction syndrome in cystic fibrosis treated by oral intestinal lavage, and a case of recurrent obstruction despite normal pancreatic function. Thorax (1987) 0.89
Clinical features, pathogenesis and management of meconium ileus equivalent. J R Soc Med (1986) 0.84
Pitfalls in the diagnosis of appendix abscess in cystic fibrosis. J R Soc Med (1989) 0.80
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol (2015) 0.79
Adult cystic fibrosis and the general surgeon. Ann R Coll Surg Engl (1994) 0.75
Emergency colonoscopy for distal intestinal obstruction syndrome in cystic fibrosis patients. Gut (2002) 0.75
Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med (1979) 3.54
Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology (1981) 2.38
Physicochemical differences of mucoproteins in duodenal fluid of patients with cystic fibrosis of the pancreas and controls; clinical aspects. Pediatrics (1957) 2.28
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Cystic fibrosis: a new outlook. 70 patients above 25 years of age. Medicine (Baltimore) (1977) 2.01
Intussusception in patients with cystic fibrosis. Pediatrics (1971) 1.71
FECAL RETENTION IN CHILDREN WITH CYSTIC FIBROSIS. REPORT OF THREE CASES. Pediatrics (1964) 1.24
Oral administration of n-acetyl cysteine in the prophylaxis of "meconium ileus equivalent". J Pediatr (1967) 1.21
LATE INTESTINAL COMPLICATIONS OF CYSTIC FIBROSIS. JAMA (1965) 1.13
Meconium ileus equivalent complicating cystic fibrosis in postneonatal children and young adults. Report of 12 cases. Gastroenterology (1977) 1.01
Infantile water intoxication after a swimming lesson. Pediatrics (1982) 1.00
MUCOVISCIDOSIS ILEUS. Acta Chir Scand (1964) 0.98
Fine structure of the urinary mucoprotein of Tamm and Horsfall as revealed by systematic depolymerization. Ann N Y Acad Sci (1963) 0.96
The islets of Langerhans in pancreatic fibrosis. Pediatrics (1958) 0.96
Intestinal obstruction as a late complication of fibrocystic disease of pancreas. Br Med J (1956) 0.91
Meconium in health and disease. Br Med Bull (1978) 0.89
CYSTIC FIBROSIS WITH FECAL RETENTION (MECONIUM ILEUS EQUIVALENT): REPORT OF TWO CASES. Mayo Clin Proc (1965) 0.81
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center. J Rheumatol (1999) 1.51
Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Does pseudomonas cross-infection occur between cystic-fibrosis patients. Lancet (1982) 1.43
Diffuse panbronchiolitis: East meets West. Eur Respir J (2007) 1.40
High prevalence of familial sarcoidosis in an Irish population. Thorax (1984) 1.20
Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int (2010) 1.20
Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax (1980) 1.14
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis (2010) 1.12
Recovery from severe paraquat poisoning following forced diuresis and immunosuppressive therapy. J Ir Med Assoc (1971) 1.12
Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax (1988) 1.10
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis (1993) 1.08
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J (2002) 1.07
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken) (2012) 1.06
Lancefield group C streptococcal endocarditis. Thorax (1974) 1.05
Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus (2006) 1.03
Granulomatous hepatitis of obscure aetiology. Diagnostic contribution of Kveim testing and anti-tuberculous therapy. Q J Med (1971) 1.02
Late referral of patients with rheumatoid arthritis to rheumatologists. Ir J Med Sci (1984) 1.01
Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax (1989) 1.01
Magnetic resonance imaging in the detection of sacroiliitis. J Rheumatol (1992) 1.00
Strength and function in the normal and rheumatoid hand. J Rheumatol (1991) 1.00
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med (1985) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheum (1986) 0.95
Massive osteolysis in the hand and response to radiotherapy. J Rheumatol (1985) 0.95
Fatal recurrence of neuroleptic malignant syndrome. Br J Psychiatry (1988) 0.95
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.93
The changing profile of tuberculosis in a general teaching hospital--a five-year review of 121 cases. Ir Med J (1982) 0.93
Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin. Clin Exp Immunol (2001) 0.92
A case of toxic epidermal necrolysis secondary to indomethacin. Br J Rheumatol (1983) 0.92
Patterns of cognitive impairment in patients with systemic lupus erythematosus. Br J Rheumatol (1993) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Breast cancer in systemic lupus erythematosus. Oncology (2013) 0.89
Lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized study comparing 750-rad treatment with 2,000-rad treatment. Arthritis Rheum (1986) 0.86
Sustained remission of lupus nephritis. Lupus (2006) 0.86
Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2014) 0.86
Biliary complications of cystic fibrosis. Gut (1992) 0.84
Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8. Exp Lung Res (2002) 0.83
Adrenal failure in systemic lupus erythematosus. J Rheumatol (1997) 0.83
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Cutaneous sarcoidosis and foreign bodies. Am J Dermatopathol (1993) 0.83
Prolonged spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis (1987) 0.83
Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Eur Respir J (1996) 0.82
Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients. Br J Clin Pract (1987) 0.82
Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels. Clin Exp Immunol (1993) 0.81
Exhaled nitric oxide and bronchoalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis. Am J Respir Crit Care Med (1997) 0.81
Value of differential thermostability, urea inhibition, and gel filtration of alkaline phosphatase in the identification of disease states. Gut (1969) 0.81
Effect of respiratory rate on airway deadspace ventilation during exercise in cystic fibrosis. Respir Med (2004) 0.80
A chest radiograph scoring system in adult cystic fibrosis: correlation with pulmonary function. Clin Radiol (1991) 0.80
Cognitive deficits in systemic lupus erythematosus. Rheum Dis Clin North Am (1993) 0.80
Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations. Neuropharmacology (1983) 0.79
Mucoid gram-negative bacilli in cystic fibrosis. Lancet (1983) 0.78
Usual and desquamative interstitial pneumonia. Chest (1976) 0.78
Occupational asthma among hospital health care personnel: a cause for concern? Thorax (1994) 0.78
Bronchoalveolar lavage collagenase and collagenase inhibitory capacity in interstitial lung disease. Biochem Soc Trans (1992) 0.77
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids. J Clin Densitom (2001) 0.77
The neuropsychiatric SLE SLICC inception cohort study. Lupus (2008) 0.77
Lymphoid irradiation in intractable rheumatoid arthritis. Long-term followup of patients treated with 750 rads or 2,000 rads. Arthritis Rheum (1989) 0.77
The effect of fibroblast conditioned medium on neutrophil survival and activation. Biochem Soc Trans (1994) 0.77
Liver lymphoma in systemic lupus erythematosus. J Rheumatol (1989) 0.77
The Systemic Lupus International Collaborating Clinics (SLICC) group - it was 20 years ago today. Lupus (2011) 0.77
Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis. Eur J Nucl Med (1986) 0.77
Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase. Am Rev Respir Dis (1990) 0.77
Nervous system involvement in systemic lupus erythematosus. Isr J Med Sci (1988) 0.76
Neuropsychiatric systemic lupus erythematosus: association with global disease activity. Lupus (2014) 0.76
Single photon emission computed tomography scanning in neuropsychiatric systemic lupus erythematosus. J Rheumatol (1998) 0.76
Peripheral nerve dysfunction in adult patients with cystic fibrosis. Ir J Med Sci (1995) 0.76
Lymphoid irradiation in intractable rheumatoid arthritis: effects on the production of immunoglobulins and rheumatoid factors. Clin Exp Immunol (1985) 0.76
The Japanese plasma cell dyscrasia syndrome: case report and theory of pathogenesis. Postgrad Med J (1982) 0.76
Tendon rupture in systemic lupus erythematosus. Ann Rheum Dis (1986) 0.75
Theophylline and depression. Br Med J (1980) 0.75
Muscle cramps, collapse, and seizures in two patients taking metolazone. Br Med J (1976) 0.75
Recurrent symptomatic pulmonary embolism caused by an infected Pudenz cerebrospinal fluid shunt device. Thorax (1978) 0.75
Fluoroscopically guided percutaneous gastrostomy in patients with cystic fibrosis. Thorax (1994) 0.75
Epilepsy and coeliac disease. J Neurol Neurosurg Psychiatry (1982) 0.75
The value of fluorinated pyrimidines in advanced malignancy. Br J Cancer (1968) 0.75
Fibroblast proliferation in vitro in response to bronchoalveolar lavage fluid. Biochem Soc Trans (1990) 0.75
Pyrexia of unknown origin, Proceedings of the first Dublin trans-city Clinico-Pathological Conference held at the Mater Hospital, May 1978. Ir Med J (1979) 0.75
Memorandum on respiratory disease services in Ireland. Ir Med J (1980) 0.75
The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis. J Antimicrob Chemother (1981) 0.75
COX-2 inhibition: not too hot, not too cold--(perhaps) just right? J Rheumatol (2000) 0.75
Atopy and cystic fibrosis. A study of CF sibling pairs and their families. Clin Allergy (1981) 0.75
Altered immunological reactivity in alveolar macrophages from patients with sarcoidosis. Eur Respir J (1988) 0.75
Human neutrophil collagenase--its isolation and purification. Biochem Soc Trans (1991) 0.75
Otitis media in infants aged 0-8 weeks: frequency of associated serious bacterial disease. Pediatr Emerg Care (1999) 0.75
Development and assessment of an immunoassay for mammalian collagenase. Biochem Soc Trans (1990) 0.75
Chronic fibrous mediastinitis as a cause of superior vena cava obstruction. Ir Med J (1983) 0.75
Malignancy prevalence in the first-degree relatives of persons with systemic lupus erythematous: a pilot study. Lupus (2006) 0.75
Tuberculin skin testing in Ireland--a survey. Ir Med J (1986) 0.75
Immunosuppressive therapy in management of non-malignant disease. J Ir Med Assoc (1970) 0.75
Decreased immunoreactive trypsin levels in sera from cystic fibrosis patients. Clin Chim Acta (1980) 0.75